Synthesis and preliminary cytotoxicity study of a cephalosporin-CC-1065 analogue prodrug
Open Access
- 2 November 2001
- journal article
- Published by Springer Nature in BMC Chemical Biology
- Vol. 1 (1) , 4
Abstract
BACKGROUND: Antibody-directed enzyme prodrug therapy (ADEPT) is a promising new approach to deliver anticancer drugs selectively to tumor cells. In this approach, an enzyme is conjugated to a tumor-specific antibody. The antibody selectively localizes the enzyme to the tumor cell surface. Subsequent administration of a prodrug substrate of the enzyme leads to the enzyme-catalyzed release of the free drug at the tumor site. The free drug will destroy the tumor cells selectively, thus, reducing side effects. RESULTS: A CC-1065 analogue was conjugated to a cephalosporin affording prodrug 2. The prodrug and its corresponding free drug, 1, have IC50 values of 0.9 and 0.09 nM, respectively, against U937 leukemia cells in vitro. CONCLUSIONS: For the first time, a prodrug comprised of a cephalosporin and a CC-1065 analogue has been synthesized. The preliminary in vitro studies show that the prodrug was 10-fold less toxic than the free drug. Prodrug 2 has the potential to be useful in cancer treatment using the ADEPT approach.Keywords
This publication has 38 references indexed in Scilit:
- Monoclonal antibody therapy for solid tumorsCancer Treatment Reviews, 2000
- Synthesis of 1-Substituted 3-(Chloromethyl)-6-aminoindoline (6-Amino-seco-CI) DNA Minor Groove Alkylating Agents and Structure−Activity Relationships for Their CytotoxicityJournal of Medicinal Chemistry, 1999
- Chemotherapeutic Drug Activation of the AP24 Protease in Apoptosis: Requirement for Caspase 3-like-ProteasesBiochemical and Biophysical Research Communications, 1998
- Unconjugated antibodies for cancer therapy: lessons from the clinicCancer Treatment Reviews, 1997
- Cephalosporin Derivatives of Doxorubicin as Prodrugs for Activation by Monoclonal Antibody-.beta.-Lactamase ConjugatesJournal of Medicinal Chemistry, 1995
- Synthesis and β-lactamase-mediated activation of a cephalosporin-taxol prodrugChemistry & Biology, 1995
- Prodrugs in cancer chemotherapyStem Cells, 1995
- Antitumor activities of a cephalosporin prodrug in combination with monoclonal antibody-.beta.-lactamase conjugatesBioconjugate Chemistry, 1993
- Monoclonal antibody-.beta.-lactamase conjugates for the activation of a cephalosporin mustard prodrugBioconjugate Chemistry, 1992
- Comparative Stability of Cephalosporins in Aqueous Solution: Kinetics and Mechanisms of DegradationJournal of Pharmaceutical Sciences, 1976